Tennessee · 114 session · house
HB 1239Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.
- Status
- Signed into law
- Latest action
- — Effective date(s) 07/01/2025
- Primary sponsor
- Helton-Haynes
- Opioids
Sponsors
- Helton-Haynes · primaryprimary
Effective dates
What law changes on each date. Different sections can land on different dates.